The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Evolva Holding Past Earnings Performance
Past criteria checks 0/6
Evolva Holding's earnings have been declining at an average annual rate of -30.8%, while the Chemicals industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 0.6% per year.
Key information
-30.76%
Earnings growth rate
-14.93%
EPS growth rate
Chemicals Industry Growth
4.35%
Revenue growth rate
0.64%
Return on equity
-1,822.84%
Net Margin
-2,434.99%
Last Earnings Update
31 Dec 2023
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Evolva Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BATS-CHIXE:EVEZ Revenue, expenses and earnings (CHF Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 23
4
-101
4
0
30 Sep 23
8
-98
7
4
30 Jun 23
12
-94
10
8
31 Mar 23
14
-69
10
9
31 Dec 22
16
-43
11
9
30 Sep 22
14
-44
11
10
30 Jun 22
12
-45
12
12
31 Mar 22
11
-43
11
12
31 Dec 21
10
-41
10
13
30 Sep 21
10
-41
10
13
30 Jun 21
10
-42
9
12
31 Mar 21
9
-36
9
13
31 Dec 20
8
-30
9
14
30 Sep 20
8
-27
10
14
30 Jun 20
9
-25
11
14
31 Mar 20
10
-23
11
14
31 Dec 19
12
-22
12
14
30 Sep 19
12
-23
12
15
30 Jun 19
11
-25
13
16
31 Mar 19
10
-27
14
17
31 Dec 18
9
-29
14
19
30 Sep 18
8
-31
16
28
30 Jun 18
7
-33
17
38
31 Mar 18
7
-36
18
33
31 Dec 17
7
-39
19
28
30 Sep 17
8
-38
18
14
30 Jun 17
10
-37
17
0
31 Mar 17
10
-37
16
0
31 Dec 16
10
-36
15
0
30 Sep 16
9
-35
14
0
30 Jun 16
9
-34
13
0
31 Mar 16
11
-33
13
0
31 Dec 15
13
-32
12
0
30 Sep 15
14
-30
12
0
30 Jun 15
14
-28
11
0
31 Mar 15
12
-25
10
0
31 Dec 14
11
-21
9
0
30 Sep 14
10
-19
9
0
30 Jun 14
10
-18
8
0
31 Mar 14
9
-17
8
0
31 Dec 13
9
-16
8
0
30 Sep 13
8
-15
7
0
30 Jun 13
7
-14
6
0
Quality Earnings: EVEZ is currently unprofitable.
Growing Profit Margin: EVEZ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EVEZ is unprofitable, and losses have increased over the past 5 years at a rate of 30.8% per year.
Accelerating Growth: Unable to compare EVEZ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EVEZ is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-18.4%).
Return on Equity
High ROE: EVEZ has a negative Return on Equity (-1822.84%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/04/26 20:06
End of Day Share Price
2024/04/24 00:00
Earnings
2023/12/31
Annual Earnings
2023/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Evolva Holding SA is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.